Beneficial effects of soybean protein and isoflavone extract supplementation on bone density and plasma lipids in females rats

• Autorzy: Ghanem K. Z.
• Języki publikacji: EN

Abstrakty

EN

The main purpose of this study was to evaluate the effect of supplementation of a soybean protein concentrate (20%) on bone mass and plasma lipid profile of adult female rats as well as to test the effectiveness of a soybean isoflavonoid extract (0.5%) in preventing bone loss due to ovariectomy. Results showed that isoflavones separated from the soybean extract contain a higher amount of isoflavonoid glycosides (daidzin and genestin) than the aglycones (diadzein and genistein). Data obtained revealed that both plasma total cholesterol and high density lipoprotein cholesterol(HDL-C) of rats were not significantly changed due to the presence of the soybean protein concentrate (20%) in the diet. On the other hand, there was a significant decrease in plasma low density lipoprotein cholesterol (LDL-C) in soy protein group. Lipid peroxidation was significantly reduced due to feeding soybean protein concentrate (20%) of the diet (approximately 30% reduction). Rats fed the soybean protein concentrate (20%) diet had significantly higher mean bone densities (10% increase) of right tibia as compared with control (protein-based diet, 20%). The ovariectomized rats fed a diet containing the isoflavonoid extract had significantly higher mean bone densities (15% increase) and bone calcium of right tibia than ovariectomized rats fed the control diet. In conclusion, the present study demonstrated that soybean protein and isoflavones could have the potential to reduce the risks of postmenopausal osteoporosis and cardiovascular diseases in such women.

Słowa kluczowe

EN

lipoprotein; soybean protein; bone density; supplementation; plasma lipid; rat; isoflavone; female

• Wydawca: -
• Czasopismo: Polish Journal of Food and Nutrition Sciences
• Rocznik: 2007
• Tom: 57
• Numer: 1
• Opis fizyczny: p.103-108,fig.,ref.

Twórcy

autor

Ghanem K. Z.

• National Research Center, Giza, Egypt

Bibliografia

• 1. Agnusdei D., Zacchei F., Bigazzi S., Cepollaro C., Nardi P., Montagnani M., Gennari C., Metabolic and clinical effects of ipriflavone in established post-menopausal osteoprosis. Drugs Exp. Clin. Res., 1989, 15, 97–104.
• 2. Allain C.C., Poon L.S., Chan C.S.G, Richmond W., Fu P.C., Enzymatic determination of total serum cholesterol. Clin. Chem., 1974, 20, 470–75.
• 3. Andersone J., Ambrose W., Garner C., Orally dosed genistein from soy and prevention of bone loss in two ovariectomized rat models. J. Nutr., 1995, 125, 799S.
• 4. Anthory M., Clarkson T., Weddle D., Wolfe M., Effects of soy protein phytoestrogens on cardiovascular risk factors in rhesus monkeys. J. Nutr., 1995, 3166, 799S–808S
• 5. Aral Y., Mariko U., Oshima K., Mitsuru T., Watanabe S., Effects of soybean isoflavones on bone mineral density and bone metabolism in human. Soy Protein Res., Japan, 2000, 21, 79–86.
• 6. Arcol I.S.B., Separation of high density lipoproteins and determination of cholesterol and phospholipids bound to these fraction. Biomerieux, 1989, 15, 121–124.
• 7. Arjmandi B., Alekel L., Hollis B., Amin D., Stacewicz-Sapuntzakis M., Guo P., Kukreja S., Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr., 1996, 126, 161–167.
• 8. Bennet A.E., Wahner H., Riggs B.L., Hintz R.L., Insulin-like growth factors I and II; aging and bone density in women. J.Clin. Endocrinol. Metab., 1984, 59, 701–704.
• 9. Benvenuti S., Tanini A., Frediani U., Bianchi S., Masi L., Casano R., Bufalino L., Serio M., Brandi M., Effects of ipriflavone and its metabolites on clonal osteoblastic cell line. J. Bone Min. Res., 1991, 6, 987–996.
• 10. Branca F., Valtuena S., Role of phytoestrogens in regulation of bone turnover. 1998, in: Bioactive plant cell wall components in nutrition and health. Proceedings of a European COST Concerted Action Scientific Workshop, 17–18 April 1998, Doorwerth, The Netherlands, pp. 200–210.
• 11. Canalis H., McCarthy T., Centrella M., Growth factors and the regulation of bone remodeling. J. Clin. Invest., 1988, 81, 277–281.
• 12. Centrella M., Canals E., Local regulators of skeletal growth: a perspective. Endocr. Rev., 1985, 6, 544–551.
• 13. Ebisawa H., Koshihara Y., Effects of dietary isoflavone-extract from soybean Hypocotyl on bone metabolism in ovariectomized young and old female rats. Soy Protein Res., Japan, 2000, 21, 87–94.
• 14. Farmakalidis E., Murphy P., Isolation of 6-O-acetylgenistin and 6-O-acetyldaidzin from toasted defatted soybean. J. Agric. Food Chem., 1985, 33, 385–389.
• 15. Friedman M., Brandon D., Nutritional and health benefits of soy proteins. J. Agric. Food Chem. May, 2001, 49, 1069–1086.
• 16. Fossati P., Prencipe L., Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem., 1982, 28, 2077–2080.
• 17. Genant H., Baylink D., Gallagher J., Estrogens in the prevention of osteoporsis in postmenopausal women. Am. J. Obstet. Gynecol., 1989, 161, 1842–1846.
• 18. Goda T., Suruge K., Takase S., Hosoya N., Dietary maltitol increases calcium content and breaking force of femoral bone in ovariectomized rats. J. Nutr., 1995, 125, 2865–2873.
• 19. Gruber H., Ivery J., Baylink D., Mathews M., Nelp W., Sisom K., Chestnut C., Long term calcitonin therapy in postmenopausal osteoporosis. Metabolism in young adult women. J. Nutr., 1984, 111, 244–251.
• 20. Hegsted D., Linkswiler H., Long term effects of level of protein intake on calcium metabolism in young adults woman. J. Nutr., 1981, 111, 244–251.
• 21. Horiuchi T., Onouchi T., Takahashi M., Ito H., Orimo H., Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteopor. Int., 2001, 11, 721–724.
• 22. Hwang J., Hodis H., Sevainan A., Soy and Alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract. J. Agric. Food Chem., 2001, 49, 308–314.
• 23. Kalu D., Liu C., Salerno E., Hollis B., Echon R., Ray M., Modulation of age-related hyperparathyroidism and senile bone loss in fisher rats by soy protein and food restriction. Endocrinology, 1988, 122, 1847–1854.
• 24. Kishida T., Ataki H., Takebe M., Ebihara K., Soybean meal fermented by Aspergillus awamori increase the cytochrome P-450 content of the liver microsomes of mice. J. Agric. Food Chem., 2000, 48, 1367–137.
• 25. Kitada Y., Ueda Y., Yamamoto M., Ishikawa M., Nakazawa H., Fujita M., Determination of isoflavones in soy bean by high-performance liquid chromatography with amperometric detection. J. Chromatogr., 1986, 366, 403–406.
• 26. Morita S., HqmamatsuY., Didd S., Taktani Y., Miyamoto K., Takeda E., Effect of soybean isoflavone on bone metabolism. Soy Protein Res., Japan, 1999, 20, 2, 76–82.
• 27. Omi N., Aoi S., Murata K., Ezawa I., Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis. J. Nutr. Sci., 1994, 40, 201–211.
• 28. Pallout J., Rimbach G., Pippig S., Schindler B., Hohler D., Most E., Dietary effect of phytogenic phytase and an addition of microbial phytase to a diet based on beans, wheat, peas and barley on the utilization of phosphorus, calcium, magnesium, zinc and protein in piglets. Z. Ernhrungswiss., 1994, 33, 128–135.
• 29. Peterson C.A., Eurell J.C., Erdman J.W., Bone composition and histology of young growing rats fed diets of varied calcium bioavailability: spinach, non fat dry milk, or calcium carbonate added to casein. J. Nutr., 1992, 122, 137–144.
• 30. Raisz L., Local and systemic factors in the pathogenesis of osteoporosis. N. Eng. J. Med., 1988, 318, 818–828.
• 31. Rudman D., Kutner M., Rogers C., Lubin M., Fleming G., Bain R., Impaired growth hormone secretion in the adult population. J. Clin. Invest., 1981, 67, 1361–1369.
• 32. Sharf M., Oettinger M., Lanir A., Kahana L., Yeshurun D., Lipid and lipoprotein levels following pure estradiol implantation in postmenopausal women. Gynecol. Obstet. Invest., 1985, 19, 207–12.
• 33. Statgraphics. Statistical Graphics System Version 2.6. Statistical Graphic Corporation, Graphic Software System Inc. 1987, U.S.sTSC.Inc.
• 34. Turner C.H., Toward a cure for osteoporosis: reversal of excessive bone fragility. Osteoporosis Int., 1991, 2, 12–19.
• 35. Uesugi T., Fukut Y., Yukio Y., Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipid in postmenopausal Japanese women: a four-week study. Am. J. Coll. Nutr., 2002, 21, April, 97–102.
• 36. Ushiyama M., Mihara M., Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem., 1978, 86, 271–278.
• 37. Yamazaki I., Effect of ipriflavone on the response of uterus and thyroid to estrogen. Life Sci., 1986, 38, 757–764.